Caren van Roekel

113 Quality of life in patients treated with 166 Ho-radioembolization SUPPLEMENTAL TABLES TABLE S1. Most important characteristics of the HEPAR I and HEPAR II patient population Characteristic HEPAR I (n=15) HEPAR II (n=38) Age (median, range) 55 (38-87) 66 (41-84) Gender (n, %) Male 9 (60%) 22 (58%) Female 6 (40%) 16 (42%) WHO performance status (n, %) 0 13 (87%) 32 (84%) 1 2 (13%) 5 (13%) 2 0 (0%) 1 (3%) Primary malignancy (n, %) Colorectal 6 (40%) 23 (61%) Breast 1 (7%) 4 (11%) Cholangiocarcinoma 2 (13%) 4 (11%) Neuroendocrine tumor 0 (0%) 2 (5%) Uveal melanoma 6 (40%) 2 (5%) Pancreas carcinoma 0 (0%) 1 (3%) Gastric cancer 0 (0%) 1 (3%) Thymoma 0 (0%) 1 (3%) Extrahepatic disease at baseline (n,%) Yes 6 (40%) 10 (26%) No 9 (60%) 28 (74%) 3